NL-OMON20139已完成不适用
Remission induction in early rheumatoid arthritis.
/A0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. RA according to ACR1987 criteria;
- •2. diagnosis RA <3 months;
- •3. age >18;
排除标准
- •Pregnancy/pregnancy wish.
研究者
相似试验
进行中（未招募）
1 期
Remission Induction in Very Early Rheumatoid Arthritis (RIVERA):a comparison of etanercept plus methotrexate plus steroid with standard therapy - RIVERAEUCTR2006-001428-38-GBniversity Hospitals Birmingham NHS Foundation Trust20
已完成
不适用
Remission Induction in Very Early Rheumatoid Arthritis: a comparison of etanercept plus methotrexate plus steroid with standard therapyISRCTN49682259Record Provided by the NHSTCT Register - 2007 Update - Department of Health20
尚未招募
4 期
Remission Induction of Very Early Rheumatoid Arthritis with Methotrexate and Etanerceptrheumatoid arthritisJPRN-C000000452Johoku Biological Summit50
Unknown
4 期
Remission Induction in Very Early Rheumatoid ArthritisRheumatoid ArthritisNCT00523692University Hospital Birmingham20
进行中（未招募）
不适用
Induction of remission in RA patients at low disease activity by additional Infliximab-therapyPatients with a diagnose of rheumatoid arthritis according to ACR-criteria at least 1 year (max. 10 years) prior to start of therapy with active disease: DAS 28 between 2,8 and 3,5 and a change in DAS 28 score <0.6 during the last 6 weeks before inclusion.EUCTR2005-004530-40-ATAESCA Pharma Ges.m.b.H160